Editorial overview: Gastrointestinal infections: An overview

Current Opinion in Gastroenterology

Volumn 20, Issue 1, 2004, Pages 1-2

  Boedeker, Edgar C ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BACTERIAL PROTEIN; CASPOFUNGIN; GANCICLOVIR; MICAFUNGIN; NITAZOXANIDE; OUTER MEMBRANE PROTEIN; PROBIOTIC AGENT; VACUOLATING TOXIN; VIRULENCE FACTOR;

BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; EDITORIAL; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITOSIS; PATHOGENESIS;

EID: 4344693521     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200401000-00002     Document Type: Editorial

References (16)

1. Yamaoka Y, Kikuchi S, El-Zimaity HM, et al.: Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002, 123:414-424.
2. Schraw W, Li Y, McClain MS, et al.: Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem 2002, 277:34642-34650.
3. Fujikawa A, Shirasaka D, Yamamoto S, et al.: Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 2003, 33:375-381.
4. Amieva MR, Vogelmann R, Covacci A, et al.: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003, 300:1430-1434.
5. Wu MS, Wu CY, Chen CJ, et al.: Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003, 104:617-623.
6. El-Omar EM, Rabkin CS, Gammon MD, et al.: Increased risk of noncardiac gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
7. Ismail HF, Fick P, Zhang J, et al.: Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003, 170:3782-3789.
8. Gebert B, Fischer W, Weiss E, et al.: Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
9. Weinstock JV, Summers RW, Elliott DE, et al.: The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med 2002, 139:334-338.
10. Khan WI, Blennerhasset PA, Varghese AK, et al.: Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immunol 2002, 70:5931-5937.
11. Dinubile MJ, Lupinacci RJ, Berman RS, et al.: Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin. AIDS Res Hum Retroviruses 2002, 18:903-908.
12. Shafran SD, Mashinter LD, Phillips P, et al.: Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy. Ann Intern Med 2002, 137:734-737.
13. Amadi B, Mwiya M, Musuku J, et al.: Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002, 360:1375-1380.
14. Van Neil CW, Feudtner C, Garrison MM, et al.: Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109:678-684.
15. D'Souza AL, Rajkumar C, Cooke J, et al.: Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002, 324:1361-1366.
16. Cremonini F, Di Carlo S, Nista EC, et al.: Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002, 16:1461-1467.